Status:

RECRUITING

A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions

Lead Sponsor:

Barbara Ann Karmanos Cancer Institute

Conditions:

Healthy

Financial Toxicity

Eligibility:

All Genders

Phase:

NA

Brief Summary

The overall goal of this research program is to address financial toxicity through the development, testing, and implementation of a multi-level communication intervention. If successful, this interve...

Detailed Description

20 Wayne State University (WSU)/Karmanos Cancer Institute (KCI) oncology care providers (e.g., medical oncologists, nurses, social workers, APP) who treat patients at the KCI Detroit and Farmington Hi...

Eligibility Criteria

Inclusion Criteria:

  • Oncology care providers at Karmanos Cancer Institute (KCI)/Wayne State University(WSU) including medical oncologists, nurses, social workers and advance practice providers who treat cancer patients at KCI Detroit or Farmington Hills clinics

Exclusion Criteria:

-

Key Trial Info

Start Date :

December 9 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2027

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT07042191

Start Date

December 9 2022

End Date

May 1 2027

Last Update

June 27 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Karmanos Cancer Institute

Detroit, Michigan, United States, 48201